Literature DB >> 15968025

Liver cancer on the rise.

Jennifer Fisher Wilson1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15968025     DOI： 10.7326/0003-4819-142-12_part_1-200506210-00024

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Ultrasound simulation of real-time temperature estimation during radiofrequency ablation using finite element models.

Authors:  M J Daniels; J Jiang; T Varghese
Journal:  Ultrasonics       Date:  2007-11-05       Impact factor: 2.890

2.  Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan.

Authors:  Ya-Wen Chen; Chien-Cheng Liu; Daw-Shyong Perng
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

3.  Human vascular adhesion proteın-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease.

Authors:  Ozgur Kemik; Aziz Sümer; Ahu Sarbay Kemik; Veyis Itik; Ahmet Cumhur Dulger; Sevim Purisa; Sefa Tuzun
Journal:  World J Surg Oncol       Date:  2010-09-17       Impact factor: 2.754

4.  Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography.

Authors:  T Abbattista; F Ridolfi; E Ciabattoni; F Marini; E Bendia; E Brunelli; P Busilacchi
Journal:  Radiol Med       Date:  2008-06-27       Impact factor: 3.469

Review 5.  Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

Authors:  Jin-Ping Lai; James R Thompson; Dalbir S Sandhu; Lewis R Roberts
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

6.  Transforming growth factor-β1 and lysophosphatidic acid activate integrin β6 gene promoter in Hep-3B cells.

Authors:  Ruirui Xu; Mingyan Xu; Yucai Fu; Xiaoling Deng; Hui Han; Xihe Chen; Wenjing He; Gengzhen Chen
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

Review 7.  Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.

Authors:  Fabio Grizzi; Barbara Franceschini; Cody Hamrick; Eldo E Frezza; Everardo Cobos; Maurizio Chiriva-Internati
Journal:  J Transl Med       Date:  2007-01-23       Impact factor: 5.531

8.  A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.

Authors:  Joe Gray; Dipankar Chattopadhyay; Gary S Beale; Gillian L Patman; Luca Miele; Barry P King; Stephen Stewart; Mark Hudson; Christopher P Day; Derek M Manas; Helen L Reeves
Journal:  BMC Cancer       Date:  2009-08-05       Impact factor: 4.430

9.  AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.

Authors:  Gary Beale; Dipankar Chattopadhyay; Joe Gray; Stephen Stewart; Mark Hudson; Christopher Day; Paolo Trerotoli; Gianluigi Giannelli; Derek Manas; Helen Reeves
Journal:  BMC Cancer       Date:  2008-07-18       Impact factor: 4.430

10.  AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.

Authors:  Lyudmyla G Glushakova; Matthew J Lisankie; Evgeniy B Eruslanov; Carolyn Ojano-Dirain; Irene Zolotukhin; Chen Liu; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2009-06-23       Impact factor: 4.797
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.